The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Circulating tumor DNA (ctDNA) analysis guiding adjuvant therapy in patients (pts) with colorectal cancer (CRC): Impact on fear of cancer recurrence (FCR).
 
Sue-Anne McLachlan
Honoraria - BMS Australia
Consulting or Advisory Role - BeiGene; Bristol-Myers Squibb
 
Rodela Mostafa
No Relationships to Disclose
 
Louise Sharpe
No Relationships to Disclose
 
Matthew Burge
Stock and Other Ownership Interests - coclear; CSL Limited; Lilly; pfizer
Honoraria - AstraZeneca; Bristol Myers squibb; Merck Sharp & Dohme; SERVIER
Consulting or Advisory Role - AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb/Medarex; merck srpe Dohme; SERVIER
Speakers' Bureau - Merck Sharpe Dohme
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - funding for an investigator initiated prospective trial (Inst)
 
Fiona Day
Speakers' Bureau - AstraZeneca
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Varian Medical Systems
Travel, Accommodations, Expenses - Merck
 
Robert Blum
No Relationships to Disclose
 
Robert Campbell
No Relationships to Disclose
 
James Lynam
Employment - Precision for Medicine
Leadership - Healthscope Advanced Pathology; Healthscope Advanced Pathology
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer
(OPTIONAL) Uncompensated Relationships - Medical Oncology Group of Australia
 
Belinda Lee
Honoraria - Roche
Research Funding - AngioDynamics (Inst); Servier (Inst); Specialised Therapeutics (Inst)
Travel, Accommodations, Expenses - Ipsen; Roche
 
Madhu Singh
No Relationships to Disclose
 
Margaret Lee
No Relationships to Disclose
 
Lorraine Chantrill
Honoraria - Amgen; Amgen; Eisai; Merck; Pierre Fabre; SERVIER
Consulting or Advisory Role - BMS Australia; MSD Oncology
Research Funding - AstraZeneca (Inst)
 
Joanne Lundy
No Relationships to Disclose
 
Zee Wan Wong
Consulting or Advisory Role - MSD Oncology
 
Rachel Wong
Consulting or Advisory Role - Bristol Meyers Squibb; MSD; MSD; MSD
Travel, Accommodations, Expenses - AstraZeneca; MSD
 
Sachin Joshi
No Relationships to Disclose
 
Ayesha Saqib
No Relationships to Disclose
 
Deme Karikios
Honoraria - Abbvie
Consulting or Advisory Role - MSD; Roche; Takeda
Travel, Accommodations, Expenses - MSD
 
Peter Gibbs
Honoraria - Bristol-Myers Squibb/Sanofi; Merck; MSD Oncology; Pierre Fabre; SERVIER
Consulting or Advisory Role - Haystack Oncology
Research Funding - Amgen (Inst); Bayer (Inst); Bristol-Myers Squibb/Sanofi (Inst); GRAIL (Inst); Haystack Oncology (Inst); Merck Serono (Inst); Pierre Fabre (Inst); Roche (Inst); Servier (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Servier
 
Jeanne Tie
Honoraria - Merck Serono; MSD Oncology
Consulting or Advisory Role - Arcus Biosciences (Inst); BeiGene; Daiichi Sankyo/Astra Zeneca (Inst); Gilead Sciences (Inst); Haystack Oncology; Illumina; MSD Oncology; Pierre Fabre; Roche; Takeda
Speakers' Bureau - MSD Oncology
Research Funding - Grail (Inst); Haystack Oncology (Inst); Pierre Fabre (Inst)